ACETAMINOPHEN TABLETS

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of 4.000 packages of acetaminophen tablets (NSN 6505014367129, NDC 00904-6730-61) at a total value of $4.32, with an award date of July 15, 2026, and a required delivery date of July 30, 2026. The contract specifies FOB DESTINATION terms, meaning the contractor bears all costs and risks until the product is delivered to the designated location at Building 1509, West 6th Street, Fort Stewart, Georgia, 31314-5185, under the Markfor identifier W33RBS. Shipment must be made by the fastest traceable means with parcel post prohibited, and inspection and acceptance occur at the destination. The product is identified through established federal supply system codes including the NSN and manufacturer CAGE code 1LEZ0, aligning with pharmaceutical procurement standards. Financial tracking is supported by project reference 7017513451, data item code A0A, funding code Z9, and agency code 97AS, though no formal accounting codes like TAS or AAC are provided. No payment office details, contracting officer representative, or invoice submission instructions are included. There are no stated packaging, marking, or barcoding requirements beyond delivery instructions, and no specific quality or inspection standards such as USP or MIL-STD are referenced. The contract contains no FAR clauses, special requirements, socioeconomic certifications, or evaluation factors, and no attachments or representations from the offeror are documented. The award appears to be a minimal-value, high-efficiency commercial supply transaction under a larger IDIQ vehicle with minimal administrative or compliance obligations beyond basic logistics and delivery compliance.